1
Gaiger Alexander, Algate Paul A, Mannion Jane, Retter Mark: Compositions and methods for the detection, diagnosis and therapy of hematological malignancies. Corixa Corporation, Gaiger Alexander, Algate Paul A, Mannion Jane, Retter Mark, SEPERACK Peter K, September 25, 2003: WO/2003/077836 (3 worldwide citation)

Disclosed are methods and compositions for the detection, diagnosis, prognosis, and therapy of hematological malignancies, and in particular, B cell leukemias, lymphomas and multiple myelomas. Disclosed are compositions, methods and kits for eliciting immune and T cell responses to specific malignan ...


2
Gaiger Alexander, Algate Paul A, Mannion Jane, Clapper Jonathan David, Wang Aijun, Ordonez Nadia, Carter Lauren, Mcneill Patricia Dianne: Compositions and methods for the detection, diagnosis and therapy of hematological malignancies. Corixa Corporation, Gaiger Alexander, Algate Paul A, Mannion Jane, Clapper Jonathan David, Wang Aijun, Ordonez Nadia, Carter Lauren, Mcneill Patricia Dianne, FANG Carol A, July 31, 2003: WO/2003/062401 (3 worldwide citation)

Disclosed are methods and compositions for the detection, diagnosis, prognosis, and therapy of hematological malignancies, and in particular, B cell leukemias, lymphomas and multiple myelomas. Disclosed are compositions, methods and kits for eliciting immune and T cell responses to specific malignan ...


3
Gaiger Alexander, Cheever Martin A, Hand Zimmermann Susan: Methods for diagnosis and therapy of hematological and virus-associated malignancies. Corixa Corporation, Gaiger Alexander, Cheever Martin A, Hand Zimmermann Susan, CHRISTIANSEN William T, February 21, 2002: WO/2002/013847 (3 worldwide citation)

The present invention is directed to methods for detecting and treating hematological and virus-associated malignancies using Her2/neu sequences. The Her2/neu sequences may be polypeptides or polynucleotides.


4
Gaiger Alexander, Cheever Martin: Composition and method for wt1-specific immunotherapy. Corixa, Gaiger Alexander, March 27, 2008: JP2008-069172 (2 worldwide citation)

PROBLEM TO BE SOLVED: To fulfill the need in the field for an improved method for prevention and therapy of leukemia and cancer and to provide other related advantages.SOLUTION: A polypeptide containing a native WT1 immunogenicity moiety or a variant thereof different in one or more substitutions, d ...


5
Wang Tongtong, Wang Siqing, Bangur Chaitanya S, Gaiger Alexander: Compositions and methods for the therapy and diagnosis of cancer. Corixa Corporation, Wang Tongtong, Wang Siqing, Bangur Chaitanya S, Gaiger Alexander, CHRISTIANSEN William T, October 10, 2002: WO/2002/078516 (1 worldwide citation)

Compositions and methods for the therapy and diagnosis of cancer, particularly cancers expressing either C-T or C-P antigens, are disclosed. Illustrative compositions comprise one or more tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen present ...


6
Gaiger Alexander, Mcneill Patricia D, Smithgall Molly, Moulton Gus, Vedvick Thomas S, Sleath Paul R, Mossman Sally, Evans Lawrence, Spies A Gregory, Boydston Jeremy: Compositions and methods for wt1 specific immunotherapy. Corixa, Gaiger Alexander, July 23, 2003: EP1328287-A1

Compositions and methods for the therapy of malignant diseases, such as leukemia and cancer, are disclosed. The compositions comprise one or more of a WT1 polynucleotide, a WT1 polypeptide, an antigen-presenting cell presenting a WT1 polypeptide, an antibody that specifically binds to a WT1 polypept ...


7

8
Gaiger Alexander, Cheever Martin: Compositions and methods for wt1 specific immunotherapy. Corixa, Gaiger Alexander, July 25, 2001: EP1117687-A2

Compositions and methods for the therapy of malignant diseases, such as leukemia and cancer, are disclosed. The compositions comprise one or more of a WT1 polynucleotide, a WT1 polypeptide, an antigen-presenting cell presenting a WT1 polypeptide, an antibody that specifically binds to a WT1 polypept ...


9
Gaiger Alexander, Cheever Martin: Compositions and methods for wt1 specific immunotherapy. Corixa Corporation, Gaiger Alexander, Cheever Martin, sMAKI David J, April 6, 2000: WO/2000/018795

Compositions and methods for the therapy of malignant diseases, such as leukemia and cancer, are disclosed. The compositions comprise one or more of a WT1 polynucleotide, a WT1 polypeptide, an antigen-presenting cell presenting a WT1 polypeptide, an antibody that specifically binds to a WT1 polypept ...


10
Gaiger Alexander, Cheever Martin A: Methods for diagnosis and therapy of hematological and virus-associated malignancies. Corixa Corporation, Gaiger Alexander, Cheever Martin A, sPOTTER Jane E R, March 29, 2001: WO/2001/021192

The present invention is directed to methods for detecting and treating hematological and virus-associated malignancies using Her2/neu sequences. The Her2/neu sequences may be polypeptides or polynucleotides.